Week 23 in the war on cancer. Here are the highlights:
-A process to get hold of AZD9291 (Tagrisso) on compassionate use from Astra Zeneca has started. We hope this will soon result in a positive outcome. We are crossing our fingers.
-As the timeline of the above process is uncertain, we will (as it looks today) go ahead with stereotactic radiation of the growing lesion in the brain. This will, if all goes to plan, happen this coming Wednesday. Originally it was scheduled on 16th February, which would have been 5 weeks after the growing lesion was discovered.